1. Home
  2. KPRX vs ABVEW Comparison

KPRX vs ABVEW Comparison

Compare KPRX & ABVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPRX
  • ABVEW
  • Stock Information
  • Founded
  • KPRX 1998
  • ABVEW N/A
  • Country
  • KPRX United States
  • ABVEW Canada
  • Employees
  • KPRX N/A
  • ABVEW N/A
  • Industry
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ABVEW Packaged Foods
  • Sector
  • KPRX Health Care
  • ABVEW Consumer Staples
  • Exchange
  • KPRX Nasdaq
  • ABVEW Nasdaq
  • Market Cap
  • KPRX 8.3M
  • ABVEW N/A
  • IPO Year
  • KPRX N/A
  • ABVEW N/A
  • Fundamental
  • Price
  • KPRX $3.12
  • ABVEW $0.04
  • Analyst Decision
  • KPRX Strong Buy
  • ABVEW
  • Analyst Count
  • KPRX 1
  • ABVEW 0
  • Target Price
  • KPRX $10.00
  • ABVEW N/A
  • AVG Volume (30 Days)
  • KPRX 11.2K
  • ABVEW N/A
  • Earning Date
  • KPRX 05-20-2025
  • ABVEW N/A
  • Dividend Yield
  • KPRX N/A
  • ABVEW N/A
  • EPS Growth
  • KPRX N/A
  • ABVEW N/A
  • EPS
  • KPRX 0.87
  • ABVEW N/A
  • Revenue
  • KPRX $16,020,000.00
  • ABVEW N/A
  • Revenue This Year
  • KPRX N/A
  • ABVEW N/A
  • Revenue Next Year
  • KPRX N/A
  • ABVEW N/A
  • P/E Ratio
  • KPRX $3.68
  • ABVEW N/A
  • Revenue Growth
  • KPRX N/A
  • ABVEW N/A
  • 52 Week Low
  • KPRX $2.51
  • ABVEW N/A
  • 52 Week High
  • KPRX $5.55
  • ABVEW N/A
  • Technical
  • Relative Strength Index (RSI)
  • KPRX 50.24
  • ABVEW N/A
  • Support Level
  • KPRX $3.18
  • ABVEW N/A
  • Resistance Level
  • KPRX $3.48
  • ABVEW N/A
  • Average True Range (ATR)
  • KPRX 0.19
  • ABVEW 0.00
  • MACD
  • KPRX 0.02
  • ABVEW 0.00
  • Stochastic Oscillator
  • KPRX 45.39
  • ABVEW 0.00

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About ABVEW Above Food Ingredients Inc. Warrants

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: